Zonisade (Zonisamide oral suspension) for Epilepsy | MyEpilepsyTeam

Connect with others who understand.

sign up Log in
Resources
About MyEpilepsyTeam
Powered By

Overview
Zonisade is a prescription medication approved by the U.S. Food and Drug Administration (FDA) as an adjunctive therapy (a therapy used with a primary treatment) to control partial-onset seizures in people 16 years and older who have epilepsy. Zonisade is also referred to by its drug name, zonisamide oral suspension.

Zonisade is an anticonvulsant — a drug used to prevent and control seizures. Zonisade is believed to work by inhibiting nerve signals in the brain.

How do I take it?
Zonisade is a liquid taken by mouth once or twice a day. Your doctor will likely start you on a low dose and gradually increase the dosage. Zonisade should be taken exactly as prescribed by a physician.

Don’t stop taking Zonisade suddenly. If you decide to stop taking Zonisade, consult your doctor for a plan to reduce your dosage gradually.

Side effects
The FDA-approved label for Zonisade states that the most common side effects include sleepiness, loss of appetite, dizziness, poor muscle control, agitation or irritability, trouble with walking and coordination, and difficulty with memory or concentration.

Less common but serious side effects of Zonisade can include allergic reactions, rashes including Stevens-Johnson syndrome (a potentially fatal rash), blood cell changes such as lower red and white blood cell counts, facial swelling, severe muscle pain, swollen lymph glands, unusual bruising or bleeding, reduced sweating, fever, eye problems, sudden pain in your back or stomach or blood in urine (signs of a kidney stone), metabolic acidosis (increased acid in blood), problems with thinking and alertness, and suicidal thoughts or behavior.

For more details about this treatment, visit:

Zonisade (Zonisamide Oral Suspension) — Azurity Pharmaceuticals
https://zonisade.com/for-patients/

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of use and Privacy policy.
Already a Member? Log in